Virulence factors and antibiotic resistance in children with helicobacter pylori gastritis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 58, Issue 5, 2014, Pages 608-612

  Karabiber, Hamza ^a   Selimoglu, Mukadder A ^a   Otlu, Baris ^b   Yildirim, Ozge ^b   Ozer, Ali ^b  

^a Department of Medicine   (United States)

^b INONU UNIVERSITY   (Turkey)

Author keywords

antibiotic resistance; children; Helicobacter pylori; virulence

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE; VIRULENCE FACTOR; BACTERIAL DNA;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CHILD; DISK DIFFUSION; GENOTYPE; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; GASTRITIS; GENETICS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GASTRITIS; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; VIRULENCE FACTORS;

EID: 84900325646     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000273     Document Type: Article

References (40)

1. Jang S, Jones KR, Olsen CH, et al. Epidemiological link between gastric disease and polymorphisms in VacA and CagA. J Clin Microbiol 2010;48:559-67.
2. Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2012;62:34-42.
3. Koletzko S, Jones NL, Goodman KJ, et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr 2011;53: 230-43.
4. McNulty C, Owen R, Tompkins D, et al. Helicobacterpylorisusceptibility testing by disc diffusion. J Antimicrob Chemother 2002;49:601-9.
5. Chomvarin C, Namwat W, Chaicumpar K, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis 2008;12:30-6.
6. Smith SI, Oyedeji KS, Arigbabu AO, et al. Comparison of three PCR methods for detection of Helicobacter pylori DNA and detection of cagA gene in gastric biopsy specimens. World J Gastroenterol 2004;10:1958-60.
7. Cirak MY, Engin D, Unal S, et al. Monitoring of Helicobacter pylori resistance to clarithromycin by real-time PCR assay in gastric biopsy specimens over a 4-year period in Turkey. Helicobacter 2007;12: 449.
8. Engin D, Cirak MY, Turet S, et al. Helicobacter pylori'de makrolid direncinden sorumlu 23S rDNA mutasyonlarinin moleküler "beacon" ile saptanmasi. 3. Ulusal Moleküler ve Tanisal Mikrobiyoloji Kongresi Bildiri Kitapçigi; Ankara 2004: 151.
9. Atherton JC, Cover TL, Twells RJ, et al. Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J Clin Microbiol 1999;37:2979-82.
10. Sezgin O, Aslan G, Altintas E, et al. Detection of point mutations on 23S rRNA of Helicobacter pylori and resistance to clarithromycin with PCR-RFLP in gastric biopsy specimens in Mersin, Turkey. Turk J Gastroenterol 2008;19:163-7.
11. Sherman PM. Appropriate strategies for testing and treating Helicobacter pylori in children: when and how? Am J Med 2004;117 (suppl 5A):30S-5S.
12. Toracchio S, Marzio L. Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002. Dig Liver Dis 2003;35:541-5.
13. Wolle K, Leodolter A, Malfertheiner P, et al. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol 2002;51:705-9.
14. Egan BJ, Katicic M, O'Connor HJ, et al. Treatment of Helicobacter pylori. Helicobacter 2007;12 (suppl 1):31-7.
15. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection: the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
16. Koletzko S, Richy F, Bontems P, et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut 2006;55:1711-6.
17. Elviss NC, Owen RJ, Xerry J, et al. Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales. J Antimicrob Chemother 2004; 54:435-40.
18. Boyanova L, Mentis A, Gubina M, et al. The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect 2002;8:388-96.
19. Ben Mansour K, Burucoa C, Zribi M, et al. Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study. Ann Clin Microbiol Antimicrob 2010;9:22.
20. Ahmad N, Zakaria WR, Mohamed R. Analysis of antibiotic susceptibility patterns of Helicobacter pylori isolates from Malaysia. Helicobacter 2010;16:47-51.
21. Talebi Bezmin Abadi A, Mobarez AM, Taghvaei T, et al. Antibiotic resistance of Helicobacter pylori in Mazandaran, North of Iran. Helicobacter 2010;15:505-9.
22. Alarcon T, Vega AE, Domingo D, et al. Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 2003;41:486-99.
23. Lopes AI, Oleastro M, Palha A, et al. Antibiotic-resistant Helicobacter pylori strains in Portuguese children. Pediatr Infect Dis J 2005;24:404-9.
24. Kalach N, Serhal L, Asmar E, et al. Helicobacter pylori primary resistant strains over 11 years in French children. Diagn Microbiol Infect Dis 2007;59:217-22.
25. Rafeey M, Ghotaslou R, Nikvash S, et al. Primary resistance in Helicobacter pylori isolated in children from Iran. J Infect Chemother 2007;13:291-5.
26. Vecsei A, Innerhofer A, Graf U, et al. Helicobacter pylori eradication rates in children upon susceptibility testing based on noninvasive stool polymerase chain reaction versus gastric tissue culture. J Pediatr Gastroenterol Nutr 2010;53:65-70.
27. Garcia GT, Aranda KR, Goncalves ME, et al. High prevalence of clarithromycin resistance and cagA, vacA, iceA2, and babA2 genotypes of Helicobacter pylori in Brazilian children. J Clin Microbiol 2010; 48:4266-8.
28. Zevit N, Levy I, Shmuely H, et al. Antibiotic resistance of Helicobacter pylori in Israeli children. Scand J Gastroenterol 2010;45:550-5.
29. Kantarçeken B, Yildirim B, Karincaoglu M, et al. Helicobacter pylori and antibiotic resistance. Turk J Gastroenterol 2000;11:141-5.
30. Can F, Yilmaz Z, Demirbilek M, et al. Diagnosis of Helicobacter pylori infection and determination of clarithromycin resistance by fluorescenceinsituhybridizationfrom formalin-fixed, paraffin-embedded gastric biopsy specimens. Can J Microbiol 2005;51:569-73.
31. Simsek H, Balaban YH, Gunes DD, et al. Alarming clarithromycin resistance of Helicobacter pylori in Turkish population. Helicobacter 2005;10:360-1.
32. Ozçay F, Kocak N, Temizel IN, et al. Helicobacter pylori infection in Turkish children: comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication. Helicobacter 2004;9:242-8.
33. Godoy AP, Ribeiro ML, Benvengo YH, et al. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol 2003;3:20.
34. Baglan PH, Bozdayi G, Ozkan M, et al. Clarithromycin resistance prevalence and Icea gene status in Helicobacter pylori clinical isolates in Turkish patients with duodenal ulcer and functional dyspepsia. J Microbiol 2006;44:409-16.
35. Boyanova L, Yordanov D, Gergova G, et al. Association of iceA and babA genotypes in Helicobacter pylori strains with patient and strain characteristics. Antonie Van Leeuwenhoek 2010;98:343-50.
36. Yakoob J, Jafri W, Abbas Z, et al. Risk factors associated with Helicobacter pylori infection treatment failure in a high prevalence area. Epidemiol Infect 2010;139:581-90.
37. Suzuki T, Matsuo K, Sawaki A, et al. Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2006;24: 273-80.
38. Sugimoto M, Yamaoka Y. Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy. Arch Immunol Ther Exp (Warsz) 2009;57:45-56.
39. Taneike I, Nami A, O'Connor A, et al. Analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status? Aliment Pharmacol Ther 2009;30:784-90.
40. Censini S, Lange C, Xiang Z, et al. CagA pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996;93:14648-53.